Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer

INTRODUCTION: Infiltration of breast tumors by tumor-infiltrating lymphocytes (TIL) has been associated with sensitivity to anthracycline-based chemotherapy. However, it is unclear whether this is true within the estrogen receptor-alpha (ER)-negative subset of breast tumors that frequently manifest...

Descripción completa

Detalles Bibliográficos
Autores principales: West, Nathan R, Milne, Katy, Truong, Pauline T, Macpherson, Nicol, Nelson, Brad H, Watson, Peter H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326568/
https://www.ncbi.nlm.nih.gov/pubmed/22151962
http://dx.doi.org/10.1186/bcr3072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326568/
https://www.ncbi.nlm.nih.gov/pubmed/22151962
http://dx.doi.org/10.1186/bcr3072

Ejemplares similares